UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to __________ Commission File Number: 001-39875 STARDUST POWER INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporati ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to __________ Commission File Number: 001-39875 STARDUST POWER INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporati ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-39281 Vancouver, British Columbia V6E 2J3 (Address of principal executive of ices) (Zip Code) (888) 458-3420 Secur ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (MARK ONE) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-42199 ADAGIO MEDICAL HOLDINGS, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware 99-1151466 (State ...

Sustainable Aviation Fuel (SAF) Production - Gevo's flagship Alcohol-to-Jet Project (ATJ-60) is expected to produce approximately 60 million gallons of sustainable aviation fuel (SAF) per year, contributing to greenhouse gas emissions reduction in the aviation industry [16]. - Global jet fuel consumption is projected to increase from approximately 92 billion gallons in 2023 to 99 billion gallons in 2024, indicating a growing market for SAF [20]. - Gevo's Alcohol-to-Jet projects utilize renewable energy and low-carbon feedstocks, aligning with the company's commitment to a sustainable energy future [16]. - The International Air Transport Association (IATA) projects that SAF will provide 62% of the carbon mitigation needed for the aviation industry to achieve net-zero emissions by 2050 [25]. - Gevo aims to achieve at least 1 billion gallons of sales in the next decade through greenfield projects and leveraging existing ethanol production capacity [28]. - The ATJ-60 project is expected to produce approximately 65 million gallons per year, including 60 million gallons of SAF, and generate around 1.3 billion pounds of high-value protein products annually [29]. Renewable Natural Gas (RNG) Production - Gevo operates one of the largest dairy-based renewable natural gas (RNG) facilities in the U.S., converting byproducts into clean energy, which diversifies revenue streams [15]. - The RNG Project in Northwest Iowa surpassed its annual production target of 310,000 million British thermal units (MMBtu) in 2023 and is expected to increase output to 400,000 MMBtu following an expansion [38]. - Gevo's revenue from the RNG segment primarily comes from environmental attributes associated with the project, including renewable identification numbers (RINs) from the EPA's Renewable Fuels Standard program [39]. - The company plans to apply a provisional Tier 2 pathway carbon intensity score to RNG production activities that occurred in Q4 2024, enhancing its market position [41]. - The GevoRNG project in Northwest Iowa has a capacity of 400,000 MMBtu of renewable natural gas (RNG) per year, with sales agreements in place for the California market [61]. Financial and Operational Challenges - The company has a history of net losses and will require substantial additional financing to achieve its growth goals, which may impact development and commercialization efforts [12]. - The company is subject to various risks, including fluctuations in feedstock prices and potential challenges in commercializing its alcohol-to-SAF projects [12]. - The company is exposed to market risks related to environmental attribute pricing, commodity pricing, interest rates, credit risk, and equity price risks [286]. - A hypothetical 10% decrease in the average realized price per RIN and LCFS credit could negatively impact operating profit by approximately $1.2 million and $0.3 million, respectively [287]. - The company's common stock price has been volatile, posing risks for future equity funding [291]. Technological Innovations and Strategies - Gevo's modularization strategy aims to improve scalability and reduce capital costs for future SAF production projects [16]. - The company focuses on low-carbon energy solutions, including the production of hydrocarbons for gasoline, diesel fuel, and chemicals, leveraging innovative technology [15]. - Gevo's technology platform aims to produce renewable liquid hydrocarbons and protein products for the food chain, enhancing its market offerings [15]. - Gevo's vertically integrated technologies and extensive patent portfolio provide a competitive advantage in driving down carbon intensity scores and maximizing production margins [44]. - The company has developed two fermentation methods for alcohol production: ethanol (2 carbons) and isobutanol (4 carbons), with isobutanol offering long-term potential for lower carbon intensity (CI) scores [49]. Regulatory and Compliance Factors - The company is subject to rigorous environmental regulations, requiring substantial resources for compliance and potential impacts on product development [72]. - The Renewable Fuel Standard (RFS) Program provides value through Renewable Identification Numbers (RINS) for the company's RNG products, which could be affected by future regulatory changes [73]. Employee and Safety Commitments - As of December 31, 2024, the company had a total of 122 employees, with 48 in Project Development and 16 in Research and Development [77]. - The company reported no reportable injuries and no lost time incidents during 2024, highlighting a strong commitment to health and safety [78]. - The company pays 100% of health, dental, and vision insurance premiums for employees and their families, despite rising costs [79]. Agricultural and Data Capabilities - The company acquired Cultivate Agricultural Intelligence, LLC in Q3 2024, enhancing its agricultural data capabilities through high-resolution drone and satellite technology [59]. - The Verity Tracking platform launched in Q2 2023 allows farmers to measure, report, and verify carbon intensity scores, providing insights into performance factors [58].

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K (Mark One) ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to ___________ Commission file number: 333-269188 Channel Therapeutics Corporation (Exact name of registrant as specified in its charter) | Nevada | 86-3335449 | | --- | --- | | (State or other jurisdiction of | (I.R.S. Employer | | incorporation or organization) | Identification No.) | ...

Revenue Performance - Total revenue for the year ended December 31, 2024, was $51,684,984, an increase of approximately $8,561,909 or 19.9% compared to $43,123,075 in 2023[144] - Revenue from the entertainment publicity and marketing segment increased by approximately $5.2 million, or 12.1%, from $43,067,557 in 2023 to $48,263,843 in 2024[144] - The content production segment generated revenue of $3,421,141 in 2024, compared to only $55,518 in 2023, marking a significant increase[141] - The entertainment publicity and marketing segment accounted for 93.4% of total revenue in 2024, down from 99.9% in 2023[141] - Revenues from content production increased by approximately $3.4 million for the year ended December 31, 2024, primarily due to the release of The Blue Angels documentary film[147] - The company recorded revenue of $3,421,141 related to the Amazon Agreement for the distribution rights of The Blue Angels documentary during the year ended December 31, 2024[215] Expenses and Financial Performance - Total expenses for the year ended December 31, 2024, were $62.2 million, a decrease of approximately $1.1 million compared to $63.2 million in 2023[148] - Direct costs increased by $2.3 million for the year ended December 31, 2024, attributed to $1.8 million of capitalized production costs for The Blue Angels and increased subsidiary revenues[148] - Payroll and benefits expenses rose by approximately $3.1 million for the year ended December 31, 2024, mainly due to a full year of Special Projects payroll and new hires[149] - Impairment of goodwill was $6.7 million for the year ended December 31, 2024, down from $9.5 million in 2023[153] - Net loss for the year ended December 31, 2024, was approximately $12.6 million or $1.22 per share, compared to a net loss of $24.4 million or $3.39 per share in 2023[167] Cash Flow and Investments - Net cash used in operating activities was approximately $0.2 million for the year ended December 31, 2024, a significant improvement from $5.0 million in 2023[169] - Cash and cash equivalents at the end of the period increased to $9.1 million as of December 31, 2024, compared to $7.6 million at the end of 2023[169] - Net cash used in investing activities for the year ended December 31, 2024 was $2.5 million, a decrease from $4.5 million in 2023[171] Debt and Financing - Total debt increased to $22.4 million as of December 31, 2024, up from $19.3 million in 2023, reflecting a $3.1 million increase[172] - The current portion of debt rose to $5.4 million from $4.9 million, primarily due to a $0.6 million increase in the current portion of the Bank United Credit Facility[173] - Interest expense related to convertible notes payable was $510,250 for the year ended December 31, 2024, down from $543,472 in 2023[186] - The principal balance of convertible promissory notes was $5.1 million as of December 31, 2024, recorded as noncurrent liabilities[185] - The company entered into a BankUnited Loan Agreement on September 29, 2023, consisting of a $5,800,000 secured term loan, a $750,000 revolving line of credit, and a $400,000 commercial card[204] - A second BankUnited Loan Agreement for $2.0 million was established on December 6, 2024, to finance the acquisition of Elle Communications, LLC, maturing in December 2027[205] Acquisitions and Strategic Initiatives - The acquisition of Elle Communications on July 15, 2024, involved a total consideration of approximately $4.7 million, including $1.9 million in cash and 961,000 shares of common stock[130] - The company has established an acquisition strategy to identify and acquire complementary businesses to enhance profits and cash flow[127] - The company plans to enter into Venture investments during 2025, focusing on entertainment content, live events, and consumer products[128] Goodwill and Impairment - The company recorded a goodwill impairment of $6.5 million in Q3 2024 due to a decline in stock price and adjusted revenue projections[220] - The company recognized an impairment of $341,417 for trademarks and trade names during the year ended December 31, 2023, due to rebranding efforts[225] Accounting and Market Risk - The company evaluates convertible debt agreements to determine if they contain both liability and equity components, classifying them as compound financial instruments[230] - Fair values of convertible debt are estimated using pricing models such as the Monte Carlo Simulation, which involves significant judgment and is subject to error risk[231] - Recent accounting pronouncements are discussed in Note 2 of the consolidated financial statements included in the Annual Report on Form 10-K[232] - Quantitative and qualitative disclosures about market risk are not required for smaller reporting companies[233]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☐ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF ...

Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION For the fiscal year ended December 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________to _______ Commission File Number: 001-41690 U.S. GOLDMINING INC. (Exact name of registrant as specified in its charter) Nevada 37-1792147 (State or other jurisdictio ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 29, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________________ to ___________________ Securities registered pursuant to Section 12(b) of the Act: Commission File Number: 001-41059 Lulu's F ...